IGF 1 LR3 Mactropin
| Features | |
| Active substance | Peptides |
| Also known as | Somatomedin C |
| Blood pressure | Can cause slight increases in blood pressure |
| Category | Peptides |
| Chemical name | Insulin-like Growth Factor 1 |
| Dosage | 0.1 Mg |
| Dosage (medical) | Typically 20-80 mcg per day, depending on condition being treated |
| Dosage (sports) | 50-150 mcg per day |
| Dosage Unit | Ml |
| ean13 | 1392806356603 |
| Effects | Increased muscle mass and strength, improved healing and recovery |
| FORM | Injection |
| Formula | C331H519N91O101S7 |
| Half-life | Approximately 10-20 hours |
| Hepatotoxicity | Low |
| Lab Test | IGF-1 levels can be measured through blood tests |
| Main action | Stimulates growth and development, anabolic effects |
| Milliliter Size | 4 Ml |
| Reference | SMCTRO37 |
| Side effects | Hypoglycemia, joint pain, increased risk of cancer, edema |
| Storage conditions | Store in a refrigerator at 2-8В°C, do not freeze |
| Substance class | Polypeptide hormone |
| Trade name | Increlex |
| Use in sports | Commonly used for muscle building and performance enhancement |
| Water Retention | Moderate |
| Packing | Vial |